As of 2026-04-05, the Fair Value of Diagnos Laboratorium Utama PT Tbk (DGNS.JK) is -38.06 IDR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 302.00 IDR, the upside of Diagnos Laboratorium Utama PT Tbk is -112.60%.
With the market price of 302.00 IDR and our fair value calculation, Diagnos Laboratorium Utama PT Tbk (DGNS.JK) is not a good investment. Investing in DGNS.JK stocks now will result in a potential loss of 112.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 52,686.54 | 64,303.51 | 12,664.89 | -13,655.81 | 747.44 | 23,349.31 |
| YoY growth | 468.07% | 22.05% | -80.30% | -207.82% | 105.47% | 61.49% |
| Market Cap (mil) | 377,500.00 |
| P/E | |
| Forward P/E | 79.66x |
| EPS | -1.52 |
| Avg earnings growth rate | 61.49% |
| TTM earnings | -1,902.95 |